AccuBoost® Digital, A Non-Invasive APBI Solution for Adaptive Breast Brachytherapy
September 30, 2019 — At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, September 15-18 in Chicago, Advanced Radiation Therapy, makers of AccuBoost® announced the latest upgrades to the AccuBoost® Digital platform. AccuBoost® Digital, leverages the excellent resolution of the Planmed Clarity digital mammography system to provide doctors with real-time image-guidance and excellent targeting confidence in the delivery of APBI in patients opting for Breast Conserving Therapy (BCT). These upgrades improve the treatment workflow, patient experience, and user interface. By design, this non-invasive breast brachytherapy (NIBB) technique is 100% adaptive as each treatment fraction is assessed independently and is ideal for the challenges that APBI treatments can present.
Adaptive therapy allows doctors the ability to alter the treatment plan based on tumor bed and anatomical changes as presented each day at the time of treatment. With AccuBoost® Digital, doctors can locate the tumor bed in real-time, and adjust the field size, shape and position as needed, while minimizing dose to a patients’ heart, lungs and healthy tissues.
“If breast cancer patients could talk to their peers that are about to embark on a course of radiation therapy, they would readily be sold on AccuBoost®. It is such a well-tolerated procedure. AccuBoost® is the only option that we offer for APBI.” – Leann Smith, MD Radiation Oncologist at Cancer Centers of Southwest Oklahoma in Lawton, OK.
About Advanced Radiation Therapy (ART)
Advanced Radiation Therapy, headquartered outside of Boston, MA, is an innovator in precision radiation therapy for breast cancer and developed the AccuBoost technology, the only non-invasive breast treatment using brachytherapy, with key opinion leaders in the industry,
AccuBoost® is a unique adaptive therapy which, unlike most breast radiation therapies, immobilizes the breast throughout imaging, targeting and treatment. This immobilization minimizes potential uncertainties in targeting. Each time a treatment is delivered, an image of the breast is taken so that the radiation oncologist can confirm the location of the target and adapt the size, shape and position of the treatment field to optimize treatment. Clinical results have been widely published showing excellent cosmesis and very low toxicity. Ultimately, the goal of BCT is to eradicate the cancer but preserve the look and feel of the woman’s breast.
Visit www.AccuBoost.com for more information.
Learn more about non-invasive adaptive breast brachytherapy for APBI here.